Showing 2401-2410 of 3223 results for "".
- Viridian Reports Positive Phase 3 Data for Subcutaneous TED Therapy, Eyes Regulatory Filinghttps://modernod.com/news/viridian-reports-positive-phase-3-data-for-subcutaneous-ted-therapy-eyes-regulatory-filing/2486438/Key Takeaways Viridian’s Phase 3 REVEAL-1 trial met its primary endpoint, showing statistically significant and clinically meaningful reductions in proptosis with subcutaneous eleg
- EssilorLuxottica Expands US Partnership Programs to Strengthen Support for Independent ECPshttps://modernod.com/news/essilorluxottica-expands-us-partnership-programs-to-strengthen-support-for-independent-ecps/2485983/Key Takeaways EssilorLuxottica has enhanced its Essilor Experts, Essilor Partners and EssilorLuxottica 360 (EL360) programs in the US to provide ind
- RevolutionEHR Announces Early Access to Redesigned Patient Portalhttps://modernod.com/news/revolutionehr-announces-early-access-to-redesigned-patient-portal/2485693/RevolutionEHR, a cloud-based electronic health record and practice management platform for optometry,
- Nidek Introduces Phantom Open-field Refraction Systemhttps://modernod.com/news/nidek-introduces-phantom-open-field-refraction-system/2485460/Nidek announced the launch of the Phantom Open-field Refraction System. Phantom is an open-field binocular refraction system that eliminates the use of physical lenses entirely—placing nothing in front of the patient’s eyes. According to Nidek, by removing this lon
- Ophthalmic World Leaders (OWL) Names First MD President and Other Leadership Changes for 2026https://modernod.com/news/ophthalmic-world-leaders-owl-names-first-md-president-and-other-leadership-changes-for-2026/2484293/Ophthalmic World Leaders (OWL) announces the appointment of Renee Bovelle, MD, as its new President. OWL also welcomes three new members to its Board of Directors: Kevin M. Douglas, MD (Medical Director, Eye Care – Retina, AbbVie), Maáza Martin (S
- Bausch + Lomb's Surgical Planning Software, Eyetelligence, Now Fully Commercially Available in UShttps://modernod.com/news/bausch-lombs-surgical-planning-software-eyetelligence-now-fully-commercially-available-in-us/2484204/Bausch + Lomb announced that its surgical planning software, Eyetelligence, is now available to all US ophthalmologists. Eyetelligence is designed to streamline a clinic’s operations and bring connectivity into the OR. According to B+L, the software helps surgeons make quick
- VEO Ophthalmics Partners with PeriVision to Bring VisionOne VR Visual Field Platform to UShttps://modernod.com/news/veo-ophthalmics-announces-us-launch-of-visionone-vr-visual-field-platform/2484203/VEO Ophthalmics announced the availability of the VisionOne VR Visual Field platform in the United States through a strategic partnership with PeriVision. This collaboration brings Switzerland-based PeriVision’s patented AI visual field-testing algorithm (SORS) to
- Artificial Intelligence-Guided Glaucoma Screening Shows Promisehttps://modernod.com/news/artificial-intelligence-guided-glaucoma-screening-shows-promise/2484195/While artificial intelligence (AI) has already proven effective in screening for diabetic retinopathy, applying similar technology to glaucoma has been more complex. Unlike diabetic retinopathy, glaucoma is not a single disease but a group of conditions characteriz
- Sight Sciences Announces Fee Schedule Establishment for TearCare Dry Eye Procedurehttps://modernod.com/news/sight-sciences-announces-fee-schedule-establishment-for-tearcare-dry-eye-procedure/2484193/Sight Sciences announced that two Medicare Administrative Contractors (MACs), Novitas Solutions and First Coast Service Options (FCSO), each established jurisdiction-wide pricing for CPT code 0563T (evacuation of meibomian glands, using heat delivered through wearable, open-eye eye
- Johnson & Johnson Marks 100,000 US Implants of Tecnis Odyssey IOL; Showcases Innovations at AAO 2025https://modernod.com/news/johnson-johnson-marks-100000-us-implants-of-tecnis-odyssey-iol-and-showcases-innovations-at-aao-2025/2484177/Johnson & Johnson announced that its Tecnis Odyssey IOL has now been implanted in 100,000 eyes since its 2024 launch. The company will highlight this milestone alongside new data presentations and technology showcases